Sourcebio International
Laboratory services for NHS, private healthcare and pharma clients: histopathology, DNA sequencing, stability storage and testing
Highlights
- New on EvolcAdded 2026-10-27
About Sourcebio International
SourceBio International provides laboratory services through four business areas: Healthcare Diagnostics (histopathology and clinical diagnostic services), Genomics (Sanger and next-generation sequencing), Stability Storage (controlled environmental storage and shelf life testing), and Infectious Disease Testing (COVID-19 antigen RT-PCR testing, offered since May 2020).
Customers include NHS and private healthcare providers in the UK and Ireland, and pharmaceutical, biotech, contract research, academic and research groups in the UK, Europe and the US. Revenues come from these four core business areas.
The company was founded in 2016 and is headquartered in Nottingham, with additional facilities in the UK, Ireland and the US. Its Executive Chairman has said the group plans to accelerate growth in Healthcare Diagnostics and Genomics, both organically and through acquisitions.
Product: Laboratory testing services: histopathology and clinical diagnostics, Sanger and next-generation sequencing, controlled environmental stability storage and shelf life testing, and COVID-19 RT-PCR testing.
Jobs at Sourcebio International
More biotech & pharma companies
SPT Labtech
Lab automation instruments for liquid handling and sample management, sold to life science research laboratoriesSpur Therapeutics
Develops gene therapies for people with chronic and debilitating diseasesNew on EvolcSpybiotech
Develops vaccines against infectious diseases and cancer using its SpyTag/SpyCatcher protein superglue platformNew on EvolcSterling Pharma Solutions
Develops and manufactures active pharmaceutical ingredients for biotech and pharmaceutical companiesNew on EvolcStirling Anglian Pharmaceuticals
Develops and supplies specialty branded medicines for UK healthcare providers and NHS stakeholdersNew on EvolcStorm Therapeutics
Clinical-stage biotech developing small-molecule RNA modifying enzyme inhibitors for cancer and other diseasesNew on Evolc
Website technologies
Older, unverified list. Detection dates and supporting evidence are not yet available.
- Complianz
- Google Analytics 4
- WordPress
- jQuery
- nginx